July 2, 2014

The Food and Drug Administration on Tuesday issued several policy documents regarding compounding as part of the agency’s continuing effort to implement the compounding provisions of the Drug Quality and Security Act enacted in November 2013. 

July 2, 2014

Actavis on Wednesday announced that its subsidiary Forest Labs has successfully completed its acquisition of Furiex Pharmaceuticals in an all-cash transaction valued at approximately $1.1 billion, and up to approximately $360 million in a Contingent Value Right that may be payable based on the status of eluxadoline, Furiex's lead product, as a controlled drug, following approval.

July 2, 2014

As many as 32 organizations on Tuesday signed a letter calling on the Food and Drug Administration to require biologics and biosimilars to have the same International Nonproprietary Name, a practice currently in use in Europe and other markets.

July 2, 2014

Ralphs Grocery Co. has announced that its 85 in-store pharmacies throughout Southern California continue to offer Tdap vaccinations as the number of pertussis cases, also known as whooping cough, reaches epidemic proportions in California.

July 2, 2014

Upsher-Smith Laboratories on Wednesday announced the launch of testosterone gel (1%), the generic of Vogelxo (testosterone) gel 1%, for topical use. Newly approved by the Food and Drug Administration, it is the first and only available generic testosterone replacement therapy available in three configurations, the company stated.

July 2, 2014

Express Scripts has taken as many as 1,000 active ingredients widely used by compounding pharmacies off of their coverage list, according to a Wall Street Journal report published Tuesday. 

July 1, 2014

Actavis and Forest Labs. on Monday announced that the U.S. Federal Trade Commission has voted to approve Actavis' proposed acquisition of Forest.

July 1, 2014

New legislation overseeing compounding pharmacies was introduced Sunday in Massachusetts, according to a report in the Boston Globe.

July 1, 2014

Walgreens is currently piloting two MedAvail self-service pharmacy kiosks — one located at one of its distribution centers and a second at an Access Health Clinic. 

June 30, 2014

AccentHealth on Thursday announced it has entered into a strategic relationship with the American Cancer Society.

June 30, 2014

Actavis on Monday confirmed that it has filed an abbreviated new drug application with the Food and Drug Administration to market buprenorphine hydrochloride and naloxone hydrochloride dihydrate sublingual tablets.

June 30, 2014

The American Pharmacists Association’s board of trustees went to Capitol Hill last week to talk to members of Congress and their staff about provider status.

June 30, 2014

Cardinal Health on Monday announced the introduction of a legislative toolkit that makes it easy for community pharmacists to share their views about policies affecting the pharmacy industry.

June 30, 2014

Afrezza, an inhaled insulin powder meant to treat diabetes patients, was approved Friday by the Food and Drug Administration.

June 30, 2014

Armada Health Care and PDX on Friday announced that Armada’s prior authorization solution, known as ApproveRx, will be integrated with the PDX Enterprise Pharmacy System, PDX Classic and Community Pharmacy system, PDX’s newest system.

June 30, 2014

Upsher-Smith Labs announced the launch of Qudexy XR (topiramate) extended-release capsules, a once-a-day antiepileptic drug engineered to provide a smooth pharmacokinetic profile.

June 28, 2014

The National Association of Boards of Pharmacy and the Anti-Diversion Industry Working Group created an educational video for pharmacists to help better combat prescription drug abuse. The video, titled "Red Flags," was released at NABP's 110th Annual Meeting.

June 27, 2014

Bayer HealthCare and HealthyWomen on Thursday launched the Family Size Matters initiative to help educate women who are done, or think they may be done, having children about their family planning, including permanent birth control.

June 27, 2014

Dr. Reddy's Labs on Friday announced the launch of duloxetine delayed-release capsules USP in 20 mg, 30 mg and 60 mg dosage strengths.

June 27, 2014

The Food and Drug Administration on Thursday notified health professionals, their provider organizations and caregivers for infants, that prescription oral viscous lidocaine 2% solution should not be used to treat infants and children with teething pain.

June 27, 2014

As the registry operator of the new .pharmacy domain, the National Association of Boards of Pharmacy, under a contract with the Internet Corporation for Assigned Names and Numbers, will soon provide a means for identifying safe online pharmacies and resources.

June 27, 2014

Ohm Labs, a wholly owned subsidiary of Ranbaxy Labs, on Friday announced that it received approval from the Food and Drug Administration to manufacture and market valsartan tablets in 40 mg, 80 mg, 160 mg and 320 mg dosage strengths.

June 27, 2014

Just two months after Labeed Diab was named head of health and wellness at Walmart, Mark Phillips was elevated to the role of VP pharmaceutical merchandising. Phillips assumes command of more than 4,175 retail pharmacy operations that generates $16.8 billion in pharmacy revenue, according to DSN's PoweRx 50. In his new role, Phillips will lead the pharmaceutical merchandising team and report to Diab. Phillips, who most recently served as the senior director of merchandising in small formats, is a long-time buyer for Walmart and may be an indication of Walmart's steadfast commitment to growing pharmacy, health and wellness, especially across Walmart's smaller formats.

June 26, 2014

The Advisory Committee on Immunization Practices on Wednesday voted to recommend a preference for using the nasal spray flu vaccine instead of the flu shot in healthy children ages 2 years to 8 years of age when it is immediately available.